Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50)
Acute limb ischemia (ALI) occurs at a rate of 1.3% per year in patients with symptomatic peripheral arterial disease (PAD) without atrial fibrillation. Vorapaxar reduces ALI in patients with symptomatic PAD including PAD resulting from graft thrombosis and in-situ thrombosis.
Source: Journal of Vascular Surgery - Category: Surgery Authors: M.P. Bonaca, J.A. Gutierrez, M.A. Creager Tags: Abstract Source Type: research
More News: Atrial Fibrillation | Cardiology | Heart | Heart Attack | Peripheral Vascular Disease (PVD) | Stroke | Surgery | Thrombosis